Science 37 Merges with eMed, Restructures, and Delists from Nasdaq

Science 37 (SNCE) has shared an announcement.

Science 37 Holdings, Inc. successfully completed a merger with eMed, LLC, and its subsidiary Marlin Merger Sub Corporation, with Science 37 becoming a wholly-owned subsidiary post-merger. Prior to the merger, a tender offer was made for all outstanding shares of Science 37 at $5.75 per share, with 77.8% of shares tendered. The total consideration for the acquisition was approximately $38 million, funded by eMed’s cash and short-term borrowing. Following the merger, Science 37’s shares were delisted from Nasdaq, and the company’s certificate of incorporation and bylaws were both amended and restated.

For detailed information about SNCE stock, go to TipRanks’ Stock Analysis page.